abagovomab 28
abciximab 24
abituzumab 19
abrilumab 12
actoxumab 15
adalimumab 14
aducanumab 9
afasevikumab 15
alacizumab_pegol 13
alemtuzumab 23
alirocumab 16
amatuximab 35
andecaliximab 20
anifrolumab 19
anrukinzumab 15
aprutumab 13
aprutumab_ixadotin 13
arcitumomab 21
ascrinvacumab 5
atezolizumab 13
atinumab 12
avelumab 9
basiliximab 25
bavituximab 29
begelomab 22
benralizumab 20
bevacizumab_beta 17
bezlotoxumab 15
bimagrumab 9
bleselumab 11
blinatumomab 33
blosozumab 24
bococizumab 15
brazikumab 10
brentuximab_vedotin 19
briakinumab 15
brodalumab 6
brolucizumab 22
brontictuzumab 17
burosumab 14
cabiralizumab 16
camrelizumab 13
canakinumab 25
cantuzumab_ravtansin 37
carlumab 13
carotuximab 24
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 18
cetiximab 33
citatuzumab_bogatox 23
cixutumumab 23
clivatuzumab_tetraxetan 16
codrituzumab 19
conatumumab 5
concizumab 25
crenezumab 11
crizanlizumab 18
crotedumab 16
dacetuzumab 17
daclizumab 14
dalotuzumab 25
dapirolizumab_pegol 21
daratumumab 13
dectrekumab 9
demcizumab 17
denosumab 11
depatuxizumab 16
depatuxizumab_mafodotin 16
dezamizumab 14
dinutuximab 32
diridavumab 13
domagrozumab 14
drozitumab 15
duligotuzumab 18
durvalumab 10
dusigitumab 8
efalizumab 26
efungumab 27
eldelumab 11
elezanumab 8
elgemtumab 9
elotuzumab 15
emactuzumab 16
emapalumab 19
emibetuzumab 12
enavatuzumab 22
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 19
enoticumab 14
ensituximab 30
eptinezumab 17
erenumab 10
etaracizumab 17
etrolizumab 16
evinacumab 17
evolocumab 10
farletuzumab 12
fasinumab 19
fezakinumab 11
fibatuzumab 7
ficlatuzumab 13
firivumab 27
flanvotumab 12
fletikumab 18
foralumab 11
foravirumab 9
fremanezumab 24
fresolimumab 16
fulranumab 15
futuximab 17
galcanezumab 15
ganitumab 18
gantenerumab 10
gemetuzumab 19
gemtuzumab2 19
gemtuzumab 23
gevokizumab 18
girentuximab 23
glembatumumab 9
glembatumumab_vedotin 9
guselkumab 19
ibalizumab 21
ibritumomab 27
icrucumab 6
idarucizumab 20
ifabotuzumab 7
imalumab 14
imgatuzumab 12
inclacumab 9
indatuximab_ravtansin 29
indusatumab 12
inebilizumab 26
intetumumab 7
iodine_girentuximab 24
ipilimumab 3
iratumumab 9
isatuximab 30
itolizumab 22
ixekizumab 22
labetuzumab_govitecan 21
lambrolizumab 23
lampalizumab 22
lanadelumab 15
landogrozumab 16
laprituximab 22
lebrikizumab 32
lendalizumab 17
lenzilumab 11
lifastuzumab_vedotin 20
ligelizumab 21
lilotomab 30
lirilumab 12
lodelcizumab 10
lokivetmab 22
lorvotuzumab_mertansin 13
lucatumumab 20
lumretuzumab 11
lupartumab 8
lutikizumab 18
margetuximab 31
milatuzumab 27
mirvetuximab 28
mirvetuximab_soravtansin 28
modotuximab 29
mogamulizumab 22
monalizumab 15
motavizumab 25
moxetumomab_pasudotox 25
namilumab 11
naratuximab 20
naratuximab_emtansin 20
narnatumab 12
navicixizumab2 23
navicixizumab 18
navivumab 29
necitumumab 6
nemolizumab 20
nesvacumab 12
nivolumab 12
obiltoxaximab 19
obinutuzumab 26
ocaratuzumab 24
ofatumumab 12
olaratumab 11
olokizumab 21
omalizumab 17
onartuzumab 16
ontuxizumab 18
opicinumab 13
orticumab 9
otelixizumab 32
oxelumab 10
ozanezumab 21
pamrevlumab 6
panobacumab 13
parsatuzumab 18
pasotuxizumab 19
pateclizumab 12
patritumab 15
pembrolizumab 23
perakizumab 16
pidilizumab 18
pinatuzumab_vedotin 13
plozalizumab 26
pogalizumab 19
polatuzumab_vedotin 16
ponezumab 29
prezalumab 12
pritoxaximab 26
quilizumab 17
racotumomab 20
radretumab 13
ralpancizumab 19
ramucirumab 13
ranevetmab 17
ranibizumab 19
refanezumab 20
remtolumab 13
rilotumumab 12
rinucumab 17
risankizumab 30
rituximab 17
rivabazumab 12
robatumumab 18
roledumab 22
romosozumab 18
rontalizumab 17
rosmantuzumab 12
rozanolixizumab 15
sacituzumab 21
sacituzumab_govitecan 21
samalizumab 20
sapelizumab 21
sarilumab 9
secukinumab 13
seribantumab 12
setoxaximab 36
sifalimumab 8
siltuximab 23
simtuzumab 19
sirukumab 10
solanezumab 19
solitomab 23
stamulumab 14
suptavumab 14
suvizumab 16
tabalumab 9
tadocizumab 11
tamtuvetmab 30
tanezumab 20
tarextumab 8
tavolixizumab 14
telisotuzumab 24
teplizumab 14
tesidolumab 15
tezepelumab 19
tigatuzumab 15
tildrakizumab 18
timolumab 9
tisotumab 9
tosatoxumab 30
tositumomab 27
tralokinumab 19
trastuzumab 19
tregalizumab 26
trevogrumab 12
ublituximab 26
urelumab 15
ustekinumab 22
utomilumab 25
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 9
vantictumab 16
vanucizumab2 17
vanucizumab 21
varlilumab 10
vatelizumab 17
vedolizumab 21
veltuzumab 12
vesencumab 11
vorsetuzumab 14
vorsetuzumab_mafodotin 14
vunakizumab 25
xentuzumab 15
zatuximab 29
